ghk-cu copper peptide research studies GHK-Cu: The Science-Backed Copper Peptide
Description
The study met its primary objective by showing a statistically significant and enhanced weight reduction at week 68 with CagriSema in comparison to placebo
BPC-157 and Anhedonia Is the Combo Making It Worse
This finding suggests that the peptide may have an impact on the course of depression
L.McCormickD.LenchN.et al (1999)
